Dr Reddys Laboratories (RDY) EBIT Growth (1y) (2010 - 2021)
Dr Reddys Laboratories (RDY) EBIT Growth (1y) (2010 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -14.89% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.25% |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 42.98% |
| Mar 31, 2021 | -19.09% |
| Sep 30, 2020 | 2.44% |
| Jun 30, 2020 | 10.68% |
| Mar 31, 2020 | -1.79% |
| Sep 30, 2019 | -198.80% |
| Jun 30, 2019 | 47.14% |
| Mar 31, 2019 | 69.70% |
| Dec 31, 2018 | 97.44% |
| Sep 30, 2018 | 7.79% |
| Dec 31, 2017 | -50.00% |
| Sep 30, 2017 | -31.25% |
| Dec 31, 2016 | -15.22% |
| Sep 30, 2016 | -1.75% |
| Dec 31, 2015 | -6.12% |
| Sep 30, 2015 | -16.79% |
| Dec 31, 2014 | -20.97% |
| Sep 30, 2014 | -2.14% |
| Mar 31, 2014 | 54.29% |
| Dec 31, 2013 | -8.82% |